Skinvisible, Inc.
SKVI
$0.23
-$0.07-23.33%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 0.00% | 0.00% | -17.70% | -91.08% | -92.84% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.00% | 0.00% | -17.70% | -91.08% | -92.84% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 0.00% | 0.00% | -4.76% | -90.95% | -92.71% |
| SG&A Expenses | 19.81% | 11.48% | 5.95% | -0.45% | -0.51% |
| Depreciation & Amortization | 10.22% | 8.06% | -0.53% | 0.00% | -0.53% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 19.46% | 11.37% | 5.02% | -1.08% | -1.43% |
| Operating Income | -20.25% | -11.86% | -6.16% | -69.32% | -105.66% |
| Income Before Tax | 76.26% | 52.24% | 54.59% | 54.16% | -94.51% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 76.26% | 52.24% | 54.59% | 54.16% | -94.51% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 76.26% | 52.24% | 54.59% | 54.16% | -94.51% |
| EBIT | -20.25% | -11.86% | -6.16% | -69.32% | -105.66% |
| EBITDA | -20.65% | -11.99% | -6.45% | -74.22% | -114.80% |
| EPS Basic | 72.10% | 52.23% | 54.59% | 54.15% | -94.48% |
| Normalized Basic EPS | 52.01% | 52.21% | 54.58% | 54.31% | -74.01% |
| EPS Diluted | 71.24% | 51.81% | 54.18% | 54.30% | -91.29% |
| Normalized Diluted EPS | 52.29% | 52.48% | 54.83% | 54.31% | -74.01% |
| Average Basic Shares Outstanding | 11.49% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 12.04% | 0.55% | 0.55% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |